No shock for USCOM
Wednesday, 08 October, 2008
Medical device company USCOM (ASX: USC) has reported that its USCOM 1A device improves management of septic shock in children, according to research published in Pediatrics.
The research was conducted at London's Great Ormond Hospital for Sick Children.
It showed that the USCOM device, which measures cardiac output, allowed earlier and more accurate detection of abnormalities in children admitted to intensive care with septic shock.
The researchers suggested that using USCOM may be an improvement on the current septic shock practice guidelines, and could allow more appropriate prescription of dugs for treatment.
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
